DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Eagle Pharmaceuticals Q4 EPS $0.49, Inline, Sales $48.258M Miss $49.07M Estimate

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.49 per share which met the analyst consensus estimate. This is a 59.17 percent decrease over earnings of $1.2 per share from the same period last

Benzinga · 03/02/2020 11:51

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.49 per share which met the analyst consensus estimate. This is a 59.17 percent decrease over earnings of $1.2 per share from the same period last year. The company reported quarterly sales of $48.258 million which missed the analyst consensus estimate of $49.07 million by 1.65 percent. This is a 13.91 percent decrease over sales of $56.054 million the same period last year.